Bacterial membrane vesicles for vaccine applications

N Krishnan, LJ Kubiatowicz, M Holay, J Zhou… - Advanced Drug Delivery …, 2022 - Elsevier
Vaccines have been highly successful in the management of many diseases. However,
there are still numerous illnesses, both infectious and noncommunicable, for which there are …

[HTML][HTML] Viral proteases as therapeutic targets

T Majerová, J Konvalinka - Molecular aspects of medicine, 2022 - Elsevier
Some medically important viruses―including retroviruses, flaviviruses, coronaviruses, and
herpesviruses―code for a protease, which is indispensable for viral maturation and …

Latency reversal plus natural killer cells diminish HIV reservoir in vivo

JT Kim, TH Zhang, C Carmona, B Lee, CS Seet… - Nature …, 2022 - nature.com
HIV is difficult to eradicate due to the persistence of a long-lived reservoir of latently infected
cells. Previous studies have shown that natural killer cells are important to inhibiting HIV …

Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1

CJ Balibar, DJ Klein, B Zamlynny… - Science Translational …, 2023 - science.org
Antiretroviral therapy inhibits HIV-1 replication but is not curative due to establishment of a
persistent reservoir after virus integration into the host genome. Reservoir reduction is …

[HTML][HTML] The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells

DC Copertino Jr, CS Holmberg, J Weiler, AR Ward… - JCI insight, 2023 - ncbi.nlm.nih.gov
IL-15 is under clinical investigation toward the goal of curing HIV infection because of its
abilities to reverse HIV latency and enhance immune effector function. However, increased …

CD4+ T cells in HIV: A Friend or a Foe?

S Govindaraj, H Babu, S Kannanganat… - Frontiers in …, 2023 - frontiersin.org
Currently, there are approximately 38.4 million individuals living with the Human
Immunodeficiency Virus (HIV), of which 36.7 million adults, 1.7 million children (< 15 years …

Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques

A Valentin, C Bergamaschi, M Rosati, M Angel… - Frontiers in …, 2022 - frontiersin.org
Immunogenicity of HIV-1 mRNA vaccine regimens was analyzed in a non-human primate
animal model. Rhesus macaques immunized with mRNA in lipid nanoparticle (mRNA/LNP) …

CD8+ T-cell responses in HIV controllers: potential implications for novel HIV remission strategies

RL Rutishauser, L Trautmann - Current Opinion in HIV and AIDS, 2022 - journals.lww.com
We propose implications as to how this knowledge from natural infection can be applied in
the design and evaluation of CD8+ T-cell-based remission strategies and offer questions to …

Human immunodeficiency virus and antiretroviral therapy-mediated immune cell metabolic dysregulation in children born to HIV-infected women: potential clinical …

H Mataramvura, MJ Bunders, K Duri - Frontiers in immunology, 2023 - frontiersin.org
Commencing lifelong antiretroviral therapy (ART) immediately following HIV diagnosis
(Option B+) has dramatically improved the health of HIV-infected women and their children …

Identification of HIV-reservoir cells with reduced susceptibility to antibody-dependent immune response

A Astorga-Gamaza, J Grau-Expósito, J Burgos… - Elife, 2022 - elifesciences.org
Human immunodeficiency virus (HIV) establishes a persistent infection in heterogeneous
cell reservoirs, which can be maintained by different mechanisms including cellular …